Last10K.com

Ampio Pharmaceuticals, Inc. (AMPE) SEC Filing 8-K Material Event for the period ending Thursday, June 23, 2022

Ampio Pharmaceuticals, Inc.

HISTORY TOOLS
CIK: 1411906 Ticker: AMPE

View differences made from one to another to evaluate Ampio Pharmaceuticals, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Ampio Pharmaceuticals, Inc..

Continue

Assess how Ampio Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Ampio Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Document And Entity Information
Ticker: AMPE
CIK: 1411906
Form Type: 8-K Corporate News
Accession Number: 0001558370-22-010261
Submitted to the SEC: Fri Jun 24 2022 3:56:14 PM EST
Accepted by the SEC: Fri Jun 24 2022
Period: Thursday, June 23, 2022
Industry: Pharmaceutical Preparations
Events:
  1. Listing Status

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/ampe/0001558370-22-010261.htm